News.

Stay up to date with the latest news about our innovation initiatives

Nano4derm is a public-private partnership project focused on the development of innovative formulations containing nanoencapsulated active ingredients for the treatment of inflammatory skin diseases, such as Acne and Psoriasis.

Almirall S.A. and Mercachem entered into an exclusive discovery collaboration focusing on the development of oral cytokine blockers for the treatment of inflammatory skin diseases.

Almirall S.A. and Nuevolution A/S entered into a global strategic collaboration focusing on the development and commercialization of Nuevolution’s novel RORγt inverse agonist (inhibitor) program for treatment of inflammatory skin diseases and disorders as well as for treatment of psoriatic arthritis.